课题基金 / 基金详情

Modification of radiation sensitivity in radiation therapy by combination of molecular target therapy

Modification of radiation sensitivity in radiation therapy by combination of molecular target therapy
结合分子靶向治疗改变放射治疗的放射敏感性
批准号:
16390334
负责人:
NAKANO Takashi
金额:
$9.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

NAKANO Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Correlations between radiation response and various biological parameters including oncogenes, apoptosis relating gene expressions of tumors and hypoxia relating proteins were investigated for prediction of radiation sensitivity predominantly relating local control probability following radiation therapy.Immunohistochemical study and various DNA/RNA analysis for human specimens were performed for obtaining parameters relating to radiation sensitivity as well as analysis for tumor cell lines and experimental animals as materials. Prognosis was analyzed by various parameters including p21, p27, p53 protein expression, inducible NOS (iNOS), Hypoxia-inducible factor-1α (HIF-1α) and Cyclooxygenase-2 (Cox-2).Of 38 patients, high expression of HIF-1α, p53, bax, and bcl-2 were seen in 17 (45%), 22 (58%), 15 (39%), and 15 (39%) patients, respectively, and 28 patients (74%) showed the positive infection with HPV. There was a significant positive correlation between high HIF-1α expression and dis … More ease recurrence (p<0.05). Furthermore, HIF-1α had a significant correlation with the recurrence free survival rate (p=0.04). No statistical significance was noted between high HIF-1α expression and local control rate (p=0.17), whereas HIF-1α status predicted distant metastasis with strong significance (p=0.03). Conversely, other factors demonstrated no impact on clinical outcome of patients with stage IIIB cervical carcinoma. HIF-1α is an important prognostic factor, especially for predicting future metastasis after radiation therapy for patients with Stage IIIB squamous cell carcinoma of the cervix.Cyclooxygenase-2 (Cox-2) impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis.COX-2 plays a pivotal role in regulation of radiation-induced apoptosis. The relationship between COX-2 expression and postradiotherapy outcomes of patients with cervical cancer was analyzed for biopsy specimens from 47 consecutive patients who had undergone definitive radiotherapy alone or radiotherapy combined with chemotherapy. The COX-2 expression rate of the pretreatment samples was 46.1% +/- 21.0%, and the apoptotic index (AI) 1 week after start of radiotherapy was 2.1% +/- 0.9%. There was a significant negative correlation between the pretreatment COX-2 expression and the AI during radiotherapy (r=-0.52, p=0.0002). Complete response rates were 59% for COX-2 positive patients compared with 80% for COX-2 negative patients (p=0.12). The 2-year local control rate for COX-2 positive patients was 71.3%, whereas the corresponding rate for COX-2 negative patients was 96.0% (p=0.06). these results firstly prove clinically that COX-2 can make cervical squamous cell carcinomas more refractory to radiotherapy by inhibition of radiation-induced apoptosis. Furthermore, expression of COX-2 may be a good indicator to predict local tumor control after radiotherapy.Bystander responses of human lung cancer cell line induced by high LET heavy-ion irradiation.Lung cancer cells were irradiated with a collimated heavy-ion microbeam single cell irradiation system, which allows selected cells to be individually hit with defined number of heavy charged particles at JAERI-Takasaki. This system has been developed to study radiobiological processes in hit cells and bystander cells exposed to low dose and low dose-rate high-LET radiations, in ways that cannot be achieved using conventional broad-field exposures. The individual cultured cells grown in special dishes were irradiated in the atmosphere with a single or defined numbers of carbon beams. Bystander effect was induced by carbon irradiation and blocked by addition of gap inhibitor. Less
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
CT-fluoroscopy guided interstitial brachytherapy with image-based trestment planning for unresectable locally recurrent rectal carcinoma
CT 透视引导间质近距离放射治疗和基于图像的治疗计划治疗不可切除的局部复发直肠癌
DOI: --
发表时间: 2004
期刊: Brachytehrapy 3・4
影响因子: --
作者: [Sakurai H, Mitsuhashi N, Harashima K, Muramatsu H, Hasegawa M, et al.]
通讯作者: et al.
DOI: 10.1016/j.ijrobp.2006.07.007
发表时间: 2006-12-01
期刊: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
影响因子: 7
作者: [Ishikawa, Hitoshi, Ohno, Tatsuya, Tsujii, Hirohiko]
通讯作者: Tsujii, Hirohiko
DOI: --
发表时间: 2005
期刊: Jpn J Hyperther Oncol 21
影响因子: --
作者: [Ishikawa H, Nakayama Y, Sakurai H, Kitamoto Y, Nonaka T, Kiyohara H, Shioya M, Wakatsuki M, Kawamura H, Hasegawa M, Nakano T]
通讯作者: Nakano T
Rectal bleeding after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy (EBRT) for localized prostate cancer : Impact of the rectal dose in high dose rate (HDR) brachytherapy on the occurrence of grade 2 or
高剂量率(HDR)近距离放射治疗联合大分割外照射放射治疗(EBRT)治疗局限性前列腺癌后直肠出血:高剂量率(HDR)近距离放射治疗中直肠剂量对2级或2级的影响
DOI: --
发表时间:
期刊: Int J Radiat Oncol Biol Phys (in press)
影响因子: --
作者: [Akimoto T, Katoh H, Kitamoto Y, Tamaki T, Harada K, Shirai K, Nakano T.]
通讯作者: Nakano T.
24
    Supply Platform of Short-lived Radioisotopes
    • 批准号:
      16H06278
    • 项目类别:
      Grant-in-Aid for Scientific Research on Innovative Areas ― Platforms for Advanced Technologies and Research Resources
    • 资助金额:
      $47.26万
    • 财政年份:
      2019
    • 负责人:
      NAKANO Takashi
    • 依托单位:
    Development of High Intensity Laser-Electron Photon beam with synchronized laser injection
    • 批准号:
      16K13806
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2016
    • 负责人:
      NAKANO Takashi
    • 依托单位:
    Basic research on Sophistication of Medical Si/CdTe compton camera
    • 批准号:
      24659557
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      NAKANO Takashi
    • 依托单位:
    Development and evaluation of a novel method for inactivation of clinical wastewater based on electrolysis
    • 批准号:
      22510091
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.0万
    • 财政年份:
      2010
    • 负责人:
      NAKANO Takashi
    • 依托单位:
    海外基金